Board meeting on November 5 to consider and approve September quarter unaudited results
Glenmark has informed the exchanges that its Board will meet on Thursday, November 5, 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Thursday, November 5, 2026
- Results Period
- quarter and half year ended September 30, 2026
- Trading Window Re-opens
- Sunday, November 08, 2026
What the company told the exchanges
Glenmark Pharmaceuticals has intimated the National Stock Exchange of India Limited and BSE Limited that a meeting of its Board of Directors will be held on Thursday, November 5, 2026. The stated purpose is to consider and approve the Unaudited Financial Results, both Standalone and Consolidated, of the company for the quarter and half year ended September 30, 2026.
When the numbers reach the market
- The results are to be submitted to the stock exchanges after the Board meeting concludes on Thursday, November 5, 2026.
- They will also be hosted on the company website on that date.
- The results will then be published in newspapers.
- So the September quarter numbers are expected to become public on the day of the meeting itself.
Trading window status
- Under the company's insider trading code, the trading window for designated persons was already closed from October 01, 2026.
- It will remain closed till the expiry of 48 hours after the September quarter results are declared.
- Accordingly, the window stays shut till Saturday, November 07, 2026.
- It re-opens on Sunday, November 08, 2026.
- Designated persons here include directors, key managerial personnel, identified employees, their immediate relatives and connected persons.
Why this matters to a retail investor
This is a notice of an upcoming event, not a results announcement. It tells you the date on which the company's September quarter and half year financial performance will be formally approved and made public. The numbers themselves - revenue, profit, segment performance - are not part of this intimation and will come with the results update on November 5, 2026.
What to watch for on the day
- The standalone and consolidated results, shared with both exchanges.
- The half year figures, since this covers both the quarter and the six months ended September 30, 2026.
What this intimation does not say
It does not contain any financial figures, guidance or business update. It is a scheduling notice, and the substantive information will follow with the results themselves.
Also from Glenmark Pharmaceuticals
Glenmark Pharmaceuticals sets Q2 FY2027 earnings call for Nov 6, 2026, 8:30–9:30 am IST
23 Oct 2026
Nomura retained buy call on Glenmark Pharma with stock up about 4.8%, raising target price to 3,750 rupees from 3,300 rupees
7 Oct 2026
US arm launches pump packs for Adapalene Gel USP, 0.1% (OTC)
6 Oct 2026
More numbers
- Trading window closure period after results (hours)48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.